PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-Jun-2023 Phastar Statistics Manager Wins Prestigious DIA Award Phastar
06-Jun-2023 GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry Newswire
06-Jun-2023 Micropep Boosts Leadership Team with Industry Veteran in Regulatory Science Businesswire
06-Jun-2023 Surgical Tourniquets Market is projected to reach US$ 812.2 Million by the end of 2029 MARKITWIRED
06-Jun-2023 Lacrimal Devices Market is anticipated to reach US$ 39.7 Million by the end of 2029 | FMI Study MARKITWIRED
06-Jun-2023 Skin Tears Treatment Market is expected to reach US$ 569.4 Million by 2029 | FMI MARKITWIRED
06-Jun-2023 Robotic Catheterization Systems Market is projected to reach US$ 112.5 Million by the end of 2029 | FMI Study MARKITWIRED
06-Jun-2023 Implantable Drug Eluting Devices Market is set to experience a significant growth of 6.0% CAGR from 2022 to 2029 MARKITWIRED
06-Jun-2023 Nerve Repair and Regeneration Market Strong Growth at a CAGR of 6.5% and Revenue to Hit USD 12.3 billion by 2030 The Wire Times
06-Jun-2023 Multiple Myeloma Market 2023 Trends: Expected to Grow at a CAGR of 10.5% by 2031, Report The Wire Times
06-Jun-2023 RWS Recognized for Exemplary ESG Performance and Best on Human Capital by EthiFinance Businesswire
06-Jun-2023 UK Organisations Prioritise Actioning Threat intelligence but Lack Clear Path to Achieve it Businesswire
06-Jun-2023 Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist Businesswire
06-Jun-2023 ELRIG UK Announces Prof Janet Hemingway and Dr Dave Powell as Keynote Speakers at Drug Discovery 2023 ELRIG UK
06-Jun-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
06-Jun-2023 EVERSANA INTOUCH Wins Five Clio Awards EVERSANA
06-Jun-2023 Injectafer® approved in the U.S. for the treatment of iron deficiency in patients with heart failure CSL Vifor
06-Jun-2023 Amolyt Pharma Announces Initiation of Phase 1 Clinical Trial of Peptide Growth Hormone Receptor Antagonist (GHRA), AZP-3813, for Acromegaly Amolyt Pharma
06-Jun-2023 BIAL announces positive results from phase 3 study in early levodopa treated Parkinson’s disease patients without motor complications BIAL
06-Jun-2023 Andexxa Phase IV trial stopped early after achieving pre-specified criteria on haemostatic efficacy versus usual care AstraZeneca